Repare Therapeutics Announces Positive Initial Data at ESMO GI from Phase 1 MINOTAUR Trial Evaluating Lunresertib in Combination with FOLFIRI

Download

• Small JPEG, 268x80, 19.3 KB
• Preview JPEG, 144x43, 10.5 KB
• Thumbnail JPEG, 120x36, 8.6 KB